With the analysis among 1,238 patents, we discovered top 158 key players by total patent application. Selecta Biosciences, Inc., NuGenerex Immuno-Oncology, Inc., ImCyse SA are dominant in this area. They take 17.21% of the total patent filing.
Selecta Biosciences, Inc.
Massachusetts, United States
Patent: 108
NuGenerex Immuno-Oncology, Inc.
Hessen, Germany
Patent: 42
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 38
F. Hoffmann-La Roche Ltd.
Genève, Switzerland
Patent: 34
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 30
International Institute of Cancer Immunology, Inc.
With the analysis among 46 patents, we discovered top 5 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, CoImmune, Inc., ImmunoMolecular Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
North Carolina, United States
Patent: 9
ImmunoMolecular Therapeutics, Inc.
Colorado, United States
Patent: 4
Worg Pharmaceuticals (Zhejiang) Co., Ltd.
Zhejiang Sheng, China
Patent: 2
With the analysis among related 305 patents applied in the last 5 years. We discover 87 most active companies in this area. The fast-growing University Health Network, ImCyse SA, Selecta Biosciences, Inc. take 27.21% of patent filing during this period.
University Health Network
Ontario, Canada
Patent: 44
Selecta Biosciences, Inc.
Massachusetts, United States
Patent: 18
Pieris Pharmaceuticals GmbH
Washington, United States
Patent: 14
NOTTINGHAM, United Kingdom
Patent: 9
Baylor College of Medicine
Texas, United States
Patent: 7
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 7
Cogen Immune Medicine, Inc.
Massachusetts, United States
Patent: 6
With the analysis among related 305 patents in last 5 years, we discover 53 new entrants. University Health Network, Sana Biotechnology, Inc., Scancell Ltd. are the most active new entrants in this area.
University Health Network
Ontario, Canada
Patent: 44
Washington, United States
Patent: 14
NOTTINGHAM, United Kingdom
Patent: 9
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 7
Cogen Immune Medicine, Inc.
Massachusetts, United States
Patent: 6
Massachusetts, United States
Patent: 4
Fukushima Medical University
Fukushima-ken, Japan
Patent: 4
NEC Laboratories Europe GmbH
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
With the analysis among 570 patents, we discovered top 67 universities and scientific research institutions by total patent application. The Johns Hopkins University, President & Fellows of Harvard College, Regents of the University of Colorado are dominant in this area. They take 21.23% of the total patent filing.
The Johns Hopkins University
President & Fellows of Harvard College
Massachusetts, United States
Patent: 28
Regents of the University of Colorado
Colorado, United States
Patent: 28
Institut Gustave Roussy EURL
Washington, United States
Patent: 12
University of Massachusetts
Massachusetts, United States
Patent: 12
Baylor College of Medicine
Texas, United States
Patent: 9